These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23908122)

  • 21. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Beddy P; Moyle P; Kataoka M; Yamamoto AK; Joubert I; Lomas D; Crawford R; Sala E
    Radiology; 2012 Feb; 262(2):530-7. PubMed ID: 22114239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy.
    Etxano J; Insausti LP; Elizalde A; López Vega JM; Plazaola A; Martínez P
    Acta Radiol; 2015 Nov; 56(11):1300-7. PubMed ID: 25348477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma.
    Wang H; Zhang X; Ye H
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1017-22. PubMed ID: 21806325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.
    Jordan BF; Runquist M; Raghunand N; Baker A; Williams R; Kirkpatrick L; Powis G; Gillies RJ
    Neoplasia; 2005 May; 7(5):475-85. PubMed ID: 15967100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.
    Port RE; Bernstein LJ; Barboriak DP; Xu L; Roberts TP; van Bruggen N
    Magn Reson Med; 2010 Aug; 64(2):408-17. PubMed ID: 20665785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
    Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
    Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
    NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
    Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
    Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.
    Wegner CS; Gaustad JV; Andersen LM; Simonsen TG; Rofstad EK
    J Transl Med; 2016 Jun; 14(1):161. PubMed ID: 27268062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of international federation of gynecology and obstetrics stage IB cervical cancer: comparison of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T.
    Lin Y; Chen Z; Kuang F; Li H; Zhong Q; Ma M
    J Comput Assist Tomogr; 2013; 37(6):989-94. PubMed ID: 24270123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
    Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
    Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
    Hompland T; Ellingsen C; Galappathi K; Rofstad EK
    Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.